Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/6976
DC FieldValueLanguage
dc.contributor.authorPozzi, Ceciliaen_us
dc.contributor.authorDi Pisa, Flavioen_us
dc.contributor.authorBenvenuti, Manuelaen_us
dc.contributor.authorMangani, Stefanoen_us
dc.date.accessioned2021-03-30T16:07:30Z-
dc.date.available2021-03-30T16:07:30Z-
dc.date.issued2018-
dc.identifier.issn0949-8257en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12779/6976-
dc.description171826en_US
dc.language.isoenen_US
dc.relationNoneen_US
dc.relation.ispartofJBICen_US
dc.subjectAlzheimer’s disease; Glutaminyl cyclase; Inhibitor; Pyroglutamate; X-ray crystallography; Biochemistry; Inorganic Chemistryen_US
dc.titleThe structure of the human glutaminyl cyclase–SEN177 complex indicates routes for developing new potent inhibitors as possible agents for the treatment of neurological disordersen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s00775-018-1605-1en_US
dc.identifier.pmid30132075en_US
dc.identifier.scopus2-s2.0-85052139884en_US
dc.identifier.isiWOS:000452210600003en_US
dc.identifier.urllink.springer.de/link/service/journals/00775/index.htmen_US
dc.relation.volume23en_US
dc.relation.issue8en_US
dc.description.firstpage1219en_US
dc.description.lastpage1226en_US
dc.description.thirdmissionNot applicableen_US
item.cerifentitytypePublications-
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeArticle-
item.fulltextNo Fulltext-
crisitem.author.orcid0000-0003-2574-3911-
crisitem.author.orcid0000-0003-4824-7478-
Appears in Collections:Publications
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.